News

ISTH News 33 Total

How ISTH Helps Early Career Professionals

New ISTH COVID-19 Guidelines Now Available

ISTH Welcomes Flora Peyvandi as President for 2022-2024 Term

Plan to Attend ISTH 2023 in Montreal!

The Importance of Attending an ISTH Congress

Joost Meijers and Nicola Mutch Discuss Basic Science Task Force

View the Latest Photos from the ISTH 2022 Congress

Miss a Session? Access Most ISTH 2022 Presentations On-Demand

Early Career Researchers Receive Editors' Awards

New Survey: Assessing Patient Awareness & Satisfaction About Information Received on the Potential Risks of Cancer-Associated VTE and Anticoagulation

ISTH 2022 Opening Ceremony Welcomes Thousands From Around the Globe

JTH Journal Editors Tout Rising Impact Factor

The Journal of Thrombosis and Haemostasis (JTH) recently recorded a historic rise in Impact Factor to 16.036. Watch JTH Editors-in-Chief James Morrissey, Ph.D. and David Lillicrap, M.D., discuss the benefits of publishing with JTH.

RPTH Editor Mary Cushman Celebrates Debut Impact Factor

Research and Practice in Thrombosis and Haemostasis (RPTH) recently received its debut Impact Factor of 5.953. Listen as RPTH Editor-in-Chief Mary Cushman talks about this momentous achievement and RPTH initiatives.

ISTH Congress Chair Beverley Hunt Welcomes You to ISTH 2022

Beverley Hunt, M.D, O.B.E., extends a warm welcome from London to all ISTH 2022 participants, both online and in-person.

SSC Chair Marc Carrier Invites Your Participation in the SSC

SSC Chair invites ISTH members to get involved in the exciting work of the Scientific and Standardization Committee (SSC).

Download the ISTH 2022 App for Access on the Go

30 Years Later: Looking Back on Professor Dominique Meyer’s Ascent to Becoming the First Female ISTH Council Chair

Communicating Science Online: Getting Started and the ‘Dos and Don’ts’

Download and View the ISTH 2022 Abstracts

Lessons From Working Abroad as a Scientist

How the ISTH Congress Impacts Members from Reach-the-World Countries

How Uncertainty and An Unexpected Email Propelled Me Into Thrombosis Research

Flora Peyvandi: Highlights on the Professional Journey of the Next ISTH President

Diagnosing Yourself: How Platelets Became the Guide to One Hematologist’s Health Problems

From the Invisible Hemophilia Carrier to the Lyonization Phenomena: A Long Way to Make Women and Girls With Hemophilia Visible

My First ISTH Congress: How Attending In-Person Again Rekindles Memories of the Past

Harnessing the Power of Visual Science Communication

ISTH Announces Official Twitter Ambassadors for the ISTH 2022 Congress in London

Apply Now to Become the Next Editor-in-Chief of JTH or RPTH

Claim Your Virtual Delegate Bag With Unique Offers and Promotions

Visit Supported Symposia and Product Theaters for Latest Updates

Visit Exhibition in London and Virtually

RPTH Publishes Illustrated State-of-the-Art Capsules in Conjunction With ISTH 2022

Roles of Factor VIII in Endothelial Cell Biology More than a Coagulation Factor

July 13, 2022 | Antonia Follenzi, M.D., Ph.D., University of Piemonte Orientale, Novara, Italy

Intermediate Versus Low-Dose Low-Molecular-Weight Heparin in Pregnant and Postpartum Women with a History of Venous Thromboembolism (Highlow Study)

July 13, 2022 | Saskia Middeldorp, M.D., Ph.D., Radboud University Medical Center, Nijmegen, the Netherlands

Sirtuin 1 as an Endogenous Inhibitor of NETosis

July 13, 2022 | Siu Ling (Christine) Wong, Ph.D., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

Platelet HMGB1 Mediates Pathological NET Formation in Ischemic Stroke

July 13, 2022 | Frederik Denorme, Ph.D., University of Utah, Salt Lake City, U.S.

The VarioPath Project: Determining Effect Sizes of Pathogenic Variants in Platelet Disorder Genes Using Clinical Data from 0.5M Whole Exome–Sequenced U.K. Biobank Participants

July 12, 2022 | Janine Collins, M.B. B.Chir., University of Cambridge, Cambridge, U.K.

Supercharged Platelets as a Novel Therapy for Reducing Blood Loss Post-Cardiac Surgery

July 12, 2022 | Alexi Crosby, D.Phil., Cambridge University, Cambridge, United Kingdom

Identification of Non-coding Genomic Regions Involved in the Etiology of Bleeding, Platelet, and Thrombotic Disorders

July 12, 2022 | Luca Stefanucci, Ph.D., University of Cambridge and Wellcome Trust Sanger Institute,

Cambridge, United Kingdom

An Integrative Approach to Diagnose Heparin-Induced Thrombocytopenia: Development, Validation, and Implementation of a Multivariable Prediction Model

July 12, 2022 | Michael Nagler, M.D., Ph.D., M.Sc., Inselspital University Hospital and University of Bern, Bern, Switzerland

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis after Laparoscopic Surgery for Colorectal Cancer

July 12, 2022 | Cecilia Becattini, M.D., University of Perugia, Perugia, Italy

FRONTIER1: A Phase 1/2 Dose Escalation Study of a Novel Factor VIIIa Mimetic Bispecific Antibody, Mim8, for Evaluation of Safety, Pharmacokinetics and Efficacy

July 11, 2022 | Pratima Chowdary, M.D., F.R.C.Path., Royal Free Hospital, London, United Kingdom

Von Willebrand Factor–Targeting Thrombolysis to Overcome Tissue Plasminogen Activator Resistance In Vivo

July 11, 2022 | Coen Maas, Ph.D., University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

Activation of the Plasma Contact System Triggers the Fat Embolism Syndrome

July 11, 2022 | Sandra Konrath, M.Sc., University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

Factor X – Protease-Activated Receptor-2 Signaling in the Regulation of Diet-Induced Obesity

July 10, 2022 | Dilraj Kaur, Ph.D. Candidate, University Medical center of Johannes Gutenberg-University, Mainz, Germany

Both α- and γ-Chain Crosslinks Mediated by FXIIIa Affect Fibrin Fiber Resistance to Rupture

July 10, 2022 | Timea Feller, Ph.D., University of Leeds, Leeds, U.K.

A Dose-Escalation Phase 1 Clinical Trial of Autologous iPSC-Derived Platelets (iPLAT1)

July 10, 2022 | Naoshi Sugimoto, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan

A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico Study

July 10, 2022 | Matthias M. Engelen, M.D., University Hospitals Leuven, Leuven, Belgium

Arterial Thromboembolism Risk Assessment Model in Hospitalized COVID-19 Patients

July 10, 2022 | Pin Li, Ph.D., Henry Ford Health, Detroit, U.S.

Validating Direct Oral Anticoagulants (DOACs) for Use in Children by the Throm-PED DOAC Registry of the International Pediatric Thrombosis Network

July 10, 2022 | Susanne Holzhauer, M.D., Charité University Medicine, Berlin, Germany

Factor XII Heavy Chain Structure

July 9, 2022 | Jonas Emsley, B.Sc., Ph.D., University of Nottingham, Nottingham, United Kingdom

High Rate of Recurrent Thrombosis in Children with Unprovoked Venous Thromboembolism

July 9, 2022 | Hilary Whitworth, M.D., Children's Hospital of Philadelphia, Philadelphia, U.S.

The Rich Inner Life of a Thrombus – “Next Generation” Analysis of Platelet Activity During Thrombus Formation in Vivo

July 9, 2022 | Niklas Boknäs, M.D., M.Sc., Ph.D., Linköping University, Department of Hematology and Department of Biomedical and Clinical Sciences, Linköping, Sweden; Pia Larsson, Ph.D., Australian Centre for Blood Diseases, Monash University, Melbourne, Australia

Management of Thrombotic Thrombocytopenic Purpura (TTP) Without Plasma Exchange: An Update on the Austrian Experience

July 9, 2022 | Paul Knoebl, M.D., Medical University of Vienna, Vienna, Austria

News

ISTH News 33 Total

Scientific News 22 Total

Industry News 5 Total

STAY UPDATED